449 related articles for article (PubMed ID: 17548162)
1. Characterization of the anticonvulsant profile of isonicotinic acid benzylamide in various experimental seizure models in mice.
Luszczki JJ; Swiader MJ; Swiader K; Paruszewski R; Turski WA; Czuczwar SJ
Neurosci Lett; 2007 Jun; 421(1):87-90. PubMed ID: 17548162
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant and acute adverse effect profiles of picolinic acid 2-fluoro-benzylamide in various experimental seizure models and chimney test in mice.
Luszczki JJ; Swiader MJ; Swiader K; Paruszewski R; Turski WA; Czuczwar SJ
Fundam Clin Pharmacol; 2008 Feb; 22(1):69-74. PubMed ID: 18005356
[TBL] [Abstract][Full Text] [Related]
3. Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice.
Świąder MJ; Łuszczki JJ; Paruszewski R; Świąder K; Turski WA
Pharmacol Rep; 2016 Apr; 68(2):297-300. PubMed ID: 26922531
[TBL] [Abstract][Full Text] [Related]
4. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
5. Effect of arachidonyl-2'-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Dudra-Jastrzebska M; Andres-Mach M; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):18-25. PubMed ID: 19751793
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant and acute neurotoxic characteristics of nicotinic acid benzylamide: a preclinical study.
Swiader MJ; Łuszczki JJ; Paruszewski R; Czuczwar SJ; Turski WA
Pharmacol Rep; 2006; 58(3):431-4. PubMed ID: 16845219
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study.
Luszczki JJ; Wojda E; Andres-Mach M; Cisowski W; Glensk M; Glowniak K; Czuczwar SJ
Epilepsy Res; 2009 Aug; 85(2-3):293-9. PubMed ID: 19406619
[TBL] [Abstract][Full Text] [Related]
8. Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model.
Luszczki JJ; Glowniak K; Czuczwar SJ
Neurosci Res; 2007 Sep; 59(1):18-22. PubMed ID: 17602770
[TBL] [Abstract][Full Text] [Related]
9. Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy.
Luszczki JJ; Czuczwar SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):529-38. PubMed ID: 17204358
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
[TBL] [Abstract][Full Text] [Related]
13. Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
Yamashita H; Ohno K; Amada Y; Hattori H; Ozawa-Funatsu Y; Toya T; Inami H; Shishikura J; Sakamoto S; Okada M; Yamaguchi T
J Pharmacol Exp Ther; 2004 Jan; 308(1):127-33. PubMed ID: 14569061
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice.
Bhutada P; Mundhada Y; Bansod K; Dixit P; Umathe S; Mundhada D
Epilepsy Behav; 2010 Jul; 18(3):207-10. PubMed ID: 20638957
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides.
Librowski T; Kubacka M; Meusel M; Scolari S; Müller CE; Gütschow M
Eur J Pharmacol; 2007 Mar; 559(2-3):138-49. PubMed ID: 17250826
[TBL] [Abstract][Full Text] [Related]
16. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
Assi AA
J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
[TBL] [Abstract][Full Text] [Related]
17. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
Swiader M; Wielosz M; Czuczwar SJ
Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
[TBL] [Abstract][Full Text] [Related]
18. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model.
Luszczki JJ; Sawicka KM; Kozinska J; Borowicz KK; Czuczwar SJ
Epilepsy Res; 2007 Aug; 76(1):66-72. PubMed ID: 17659862
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the anticonvulsant potency of various benzylamide derivatives in the mouse maximal electroshock-induced seizure threshold model.
Świąder MJ; Paruszewski R; Łuszczki JJ
Pharmacol Rep; 2016 Apr; 68(2):259-62. PubMed ID: 26922525
[TBL] [Abstract][Full Text] [Related]
20. Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models.
Blanco MM; dos Santos JG; Perez-Mendes P; Kohek SR; Cavarsan CF; Hummel M; Albuquerque C; Mello LE
Epilepsia; 2009 Apr; 50(4):824-31. PubMed ID: 19054404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
